Arit Industries Subsidiary Secures $16.3 Million North American Fuze Order
Arit Industries subsidiary Reshef Technologies secured a $16.3 million North American order for artillery fuzes, boosting its backlog to 540 million shekels ahead of 2027 deliveries.
Arit Industries announced that its subsidiary, Reshef Technologies, has secured a $16.3 million order from a major North American defense contractor to supply artillery fuzes. Valued at approximately 50 million shekels, the delivery is scheduled for the second quarter of 2027, pending export approval from the Ministry of Defense.
Arit Industries is a publicly traded company on the Tel Aviv Stock Exchange, controlled by Tiberias businessman Zvi Levy, who holds a 39% stake. The core of its operations is conducted through Reshef Technologies, in which Arit holds a 77.6% stake, operating a production plant in Sderot that supplies fuzes to the IDF as well.
Products and International Expansion
A fuze is the critical component that determines when and how ammunition detonates. Reshef specializes in electronic fuzes for artillery shells, mortar bombs, and tank ammunition, alongside developing products for loitering munitions and drones. In June 2024, the Ministry of Defense ordered fuzes from the Sderot plant worth 210 million shekels.
While the client's identity and specific country were not disclosed, CEO Haim Stipler noted last month that this North American client previously ordered fuzes worth approximately $83 million in 2024, delivered throughout 2025. Following an additional tender won by the client in September, the formal order has now been finalized.
Global Reach and Order Backlog
Reshef's operations extend beyond North America. The company collaborates with Indian defense giant BEL under a multi-year agreement and seeks to expand its footprint in Europe. In the United States, Reshef plans to establish a fuze manufacturing plant in Georgia, having acquired land for about $2 million despite an ongoing legal dispute regarding a portion of the property.
Arit's current order backlog stands at approximately 540 million shekels, excluding an additional conditional order from India valued at around $45 million. Despite international expansion efforts, the company's stock has declined significantly from its peak this year amid a revenue slowdown, leaving investors watching whether the new North American order will spur a recovery.
